We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cancer Cells’ “Self-eating” Could Be Novel Drug Target

News   Jul 02, 2019 | Original story from Cold Spring Harbor Laboratory (CSHL)

 
Cancer Cells’ “Self-eating” Could Be Novel Drug Target

Evidence of activity involving the NIX protein (brown staining) is seen in common precursor lesions (PanIN) for pancreatic cancer. NIX activity escalates in full pancreatic ductal adenocarcinoma (PDAC), the most common of pancreas cancers. NIX is directly responsible for triggering mitophagy, or "self eating" of mitochondria. Credit: Tuveson lab/CSHL

 
 
 

RELATED ARTICLES

Leukemia Cells Transform into Non-cancerous Cells

News

Researchers describe how a leukemia Type B cell can transform into a different cell, a macrophage, changing its epigenome and consecutively getting a new cellular identity.

READ MORE

Mathematical Method Provides Deeper Understanding of Drug Interactions

News

Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences have developed a new methodology characterizing more precisely how drugs influence each other when combined during treatment.

READ MORE

Could Anthrax Help Fight Bladder Cancer?

News

A team from Purdue University has come up with a way to combine the anthrax toxin with a growth factor to kill bladder cancer cells and tumors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE